drugset / Trial / NCT00638989
A Study to Assess Bioavailability and Pharmacokinetics of CAT- 354
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare bioavailability and pharmacokinetics of CAT-354 following subcutaneous administration compared with intravenous administration.
Timeline
- Start
- 2008-04-11
- Primary completion
- 2008-06-07
- Completion
- 2008-06-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tralokinumab | Monoclonal antibody | 150 mg | Intravenous |
| Subject | Tralokinumab | Monoclonal antibody | 300 mg | Intravenous |